Yohann Loriot Selected Research

1- (1- ((5- methoxy- 1H- indol- 2- yl)carbonyl)piperidin- 4- yl)- 2- methylpropan- 2- ol

10/2014

Safety, tolerability and anti-tumour activity of the androgen biosynthesis inhibitor ASP9521 in patients with metastatic castration-resistant prostate cancer: multi-centre phase I/II study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yohann Loriot Research Topics

Disease

56	Neoplasms (Cancer) 11/2022 - 05/2008
48	Prostatic Neoplasms (Prostate Cancer) 05/2022 - 05/2009
36	Carcinoma (Carcinomatosis) 07/2022 - 02/2016
17	Neoplasm Metastasis (Metastasis) 07/2022 - 05/2009
13	Urinary Bladder Neoplasms (Bladder Cancer) 07/2022 - 05/2012
13	Disease Progression 11/2021 - 10/2014
8	Renal Cell Carcinoma (Grawitz Tumor) 11/2021 - 05/2013
7	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2020 - 09/2009
5	Seminoma 01/2022 - 02/2007
5	Pain (Aches) 11/2021 - 05/2009
4	Pneumonia (Pneumonitis) 12/2020 - 09/2009
4	Circulating Neoplastic Cells 01/2020 - 04/2014
4	Hypertension (High Blood Pressure) 01/2018 - 12/2009
3	Fatigue 01/2021 - 07/2014
3	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 01/2019
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2019 - 08/2013
3	Lung Neoplasms (Lung Cancer) 12/2016 - 12/2009
3	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 07/2013 - 02/2010
2	Diarrhea 06/2022 - 01/2021
2	Body Weight (Weight, Body) 01/2021 - 12/2020
2	Neutropenia 01/2021 - 12/2020
2	Colitis 01/2021 - 10/2017
2	Non-Muscle Invasive Bladder Neoplasms 07/2020 - 06/2020
2	Sarcoma (Soft Tissue Sarcoma) 01/2020 - 02/2010
1	Urinary Tract Infections (Urinary Tract Infection) 06/2022
1	Renal Insufficiency (Renal Failure) 12/2021
1	Sepsis (Septicemia) 01/2021

Drug/Important Bio-Agent (IBA)

21	Immune Checkpoint InhibitorsIBA 01/2022 - 05/2016
20	Cisplatin (Platino)FDA LinkGeneric 07/2022 - 09/2009
19	enzalutamideIBA 01/2022 - 07/2014
19	atezolizumabIBA 01/2022 - 11/2014
16	PlatinumIBA 01/2022 - 05/2012
13	Docetaxel (Taxotere)FDA Link 01/2021 - 05/2009
13	AndrogensIBA 12/2020 - 05/2011
8	Androgen Receptors (Androgen Receptor)IBA 01/2020 - 11/2012
7	Biomarkers (Surrogate Marker)IBA 07/2022 - 12/2009
7	abirateroneIBA 01/2022 - 05/2011
6	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 02/2007
6	Tyrosine Kinase InhibitorsIBA 01/2022 - 05/2008
6	erdafitinibIBA 01/2022 - 01/2019
6	B7-H1 AntigenIBA 01/2021 - 11/2014
5	Pharmaceutical PreparationsIBA 01/2021 - 05/2008
5	Prostate-Specific Antigen (Semenogelase)IBA 10/2020 - 05/2009
5	Abiraterone AcetateIBA 01/2020 - 05/2011
5	Prednisone (Sone)FDA LinkGeneric 01/2020 - 05/2011
4	Gemcitabine FDA Link 01/2021 - 05/2012
4	ErbB Receptors (EGF Receptor)IBA 01/2021 - 12/2009
4	Monoclonal AntibodiesIBA 01/2021 - 05/2008
4	cabazitaxel FDA Link 01/2019 - 08/2015
4	Taxoids (Taxanes)IBA 01/2018 - 06/2013
3	avelumabIBA 06/2022 - 01/2020
3	durvalumabIBA 01/2022 - 01/2018
3	Fibroblast Growth Factor Receptors (Fibroblast Growth Factor Receptor)IBA 01/2022 - 01/2019
3	Hormones (Hormone)IBA 11/2021 - 01/2015
3	Paclitaxel (Taxol)FDA LinkGeneric 01/2021 - 01/2018
3	pembrolizumabIBA 01/2021 - 01/2019
3	vinflunineIBA 01/2021 - 01/2018
3	taxaneIBA 01/2019 - 01/2016
3	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2017 - 12/2009
2	Circulating Tumor DNAIBA 11/2022 - 12/2020
2	Poly(ADP-ribose) Polymerase InhibitorsIBA 05/2022 - 10/2018
2	cabozantinibIBA 01/2022 - 11/2021
2	Biological ProductsIBA 12/2021 - 12/2009
2	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021 - 05/2012
2	enfortumab vedotinIBA 01/2021 - 01/2021
2	AntibodiesIBA 01/2021 - 01/2018
2	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021 - 05/2012
2	Methotrexate (Mexate)FDA LinkGeneric 01/2021 - 05/2012
2	Estramustine FDA Link 12/2020 - 05/2009
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 12/2020 - 01/2020
2	Testosterone (Sustanon)FDA Link 12/2020 - 05/2015
2	cyclo(Arg-Pro) (CI 4)IBA 01/2020 - 04/2018
2	LigandsIBA 01/2020 - 01/2018
2	RNA (Ribonucleic Acid)IBA 01/2019 - 01/2017
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019 - 05/2015
2	RadiumIBA 01/2019 - 11/2015
2	Axitinib (AG 013736)IBA 12/2017 - 01/2017
2	Everolimus FDA Link 12/2017 - 04/2014
2	CrizotinibIBA 12/2016 - 02/2016
2	Sorafenib (BAY 43-9006)FDA Link 04/2014 - 04/2014
1	Cell-Free Nucleic AcidsIBA 11/2022
1	infigratinibIBA 07/2022
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 05/2022
1	Etoposide (VP 16)FDA LinkGeneric 01/2022
1	Immunologic Factors (Immunomodulators)IBA 11/2021
1	Analgesics (Analgesic Drugs)IBA 08/2021
1	sacituzumab govitecanIBA 01/2021
1	bempegaldesleukinIBA 01/2021

Therapy/Procedure

52	Drug Therapy (Chemotherapy) 06/2022 - 06/2006
52	Therapeutics 01/2022 - 05/2008
39	Castration 01/2022 - 05/2009
9	Immunotherapy 06/2022 - 11/2014
6	Adjuvant Chemotherapy 07/2022 - 01/2017
6	Radiotherapy 10/2020 - 06/2006
5	Cystectomy 05/2021 - 01/2017
4	Precision Medicine 08/2021 - 01/2014
3	Combination Drug Therapy (Combination Chemotherapy) 12/2021 - 02/2016
2	Aftercare (After-Treatment) 01/2021 - 05/2009
2	Neoadjuvant Therapy 12/2020 - 12/2020
2	Lymph Node Excision (Lymph Node Dissection) 12/2020 - 08/2019